Learn when high-risk skin SCC needs early oncology referrals, imaging, and coordinated tumor-board care to avoid delays and improve outcomes.
Gaurav Singh, MPH, FACMS
Advertisement
Articles by Gaurav Singh, MPH, FACMS
Learn how clinicians spot aggressive cutaneous squamous cell carcinoma and when multidisciplinary care and immunotherapy improve outcomes.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Ziftomenib Plus 7+3 Yields High Response Rates in Newly Diagnosed AML
2
Pirtobrutinib Plus Venetoclax/Rituximab Improves PFS in Pretreated CLL
3
Capivasertib Combo Earns FDA Approval in PTEN-Deficient Metastatic HSPC
4
Sonrotoclax Plus Zanubrutinib Achieves >90% uMRD in Treatment-Naive CLL/SLL
5